Improve Kidney Function With IV Laser Treatment

If you're one of the more than 20 million Americans who suffer from chronic kidney disease (CKD), your doctor has probably told you there isn't much they can do for you. Mainstream medicine doesn't have a cure for CKD. What they do have is a lot of drugs to treat the symptoms of it. And most of the drugs will leave you worse off than before you started taking them… Like ESAs, which are prescribed to treat anemia caused by chronic kidney disease. These dangerous drugs can cause strokes, heart attacks, blood clots and seizures. And if your kidneys fail, your only options are dialysis or a kidney transplant. It's enough to leave you feeling hopeless… But I'm here to tell you there IS hope. It's called intravenous laser blood therapy, or IV laser treatment. And it's been shown to slow the progression of CKD.1 So why haven't you heard this from your doctor? Because Big Pharma has a vice-like grip on the "disease industry" in this country. And if a treatment doesn't boost their bottom line, they want to act like it doesn't exist. And the worst part is that IV laser treatment isn't new. It's been around for decades. IV blood lasers were first used in the old Soviet Union more than 25 years ago. But don't get them confused with surgical lasers used to cut, cauterize and burn out diseased tissue. I'm talking about "soft lasers." They operate at lower power. Instead of destroying tissues, they rep...
Source: Al Sears, MD Natural Remedies - Category: Complementary Medicine Authors: Tags: Anti-Aging Source Type: news

Related Links:

CONCLUSION: Our results suggest that the use of a BCI after SA does not lead to increased consumption of medical care. PMID: 30551792 [PubMed - as supplied by publisher]
Source: L Encephale - Category: Psychiatry Tags: Encephale Source Type: research
Publication date: Available online 16 December 2018Source: Redox BiologyAuthor(s): Mateusz A. Stochelski, Tomasz Wilmanski, Mitchell Walters, John R. BurgessAbstractDiabetes mellitus is one of the most common chronic diseases in the United States and peripheral neuropathy (PN) affects at least 50% of diabetic patients. Medications available for patients ameliorate symptoms (pain), but do not protect against cellular damage and come with severe side effects, leading to discontinued use. Our research group uses differentiated SH-SY5Y cells treated with advanced glycation end products (AGE) as a model to mimic diabetic condit...
Source: Redox Biology - Category: Biology Source Type: research
Authors: Harsch IA, Kaestner RH, Konturek PC Abstract Insulinotropic oral antidiabetics (OAD) such as sulfonylureas and (SU) glinides are among the frequently prescribed OAD. Side effects are the potential to induce hypoglycemias and weight gain. The aim was to assess the self-managing skills in case of a hypoglycemic event in an elderly type 2 diabetic patient population. In a 2-year period, 160 hospitalized patients (mean age 77.4 years) under insulinotrophic OAD were interviewed using a standardized questionnaire. Additionally, possible dementia was evaluated by using the Mini-Mental State Examination (MMSE) and...
Source: Journal of Physiology and Pharmacology - Category: Drugs & Pharmacology Tags: J Physiol Pharmacol Source Type: research
Authors: Skowron B, Baranowska A, Dobrek L, Ciesielczyk K, Kaszuba-Zwoinska J, Wiecek G, Malska-Wozniak A, Strus M, Gil K Abstract Recent evidence suggests that neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), cystatin C (CysC), uromodulin (UMOD), and some interleukins (IL-6 and IL-18) can be considered as diagnostic markers of acute kidney injury (AKI). The aim of this study was to verify the applicability of four urinary (u) markers, namely uNGAL, uKIM-1, uCysC, and uUMOD, for the diagnosis of ascending AKI induced by bacterial pyelonephritis. The study included 30 female rats ...
Source: Journal of Physiology and Pharmacology - Category: Drugs & Pharmacology Tags: J Physiol Pharmacol Source Type: research
Authors: Jastrzebska M, Marcinowska Z, Oledzki S, Chelstowski K, Siennicka A, Klysz M, Clark JS Abstract Antiplatelet therapy is considered as a standard procedure against atherosclerotic cardiovscular disease but this therapy has limited effect if resistance to acetylsalicylic acid or clopidogrel is present. Important factors associated with resistance are gender; or inflammation possibly associated with membrane microparticles (MP). It was decided to challenge the hypothesis that differential responses to dual antiplatelet therapy are conditioned by gender and/or proinflammatory status. The study involved 160 pat...
Source: Journal of Physiology and Pharmacology - Category: Drugs & Pharmacology Tags: J Physiol Pharmacol Source Type: research
Authors: Schink M, Konturek PC, Tietz E, Dieterich W, Pinzer TC, Wirtz S, Neurath MF, Zopf Y Abstract Histamine intolerance represents a controversially discussed disorder. Besides an impaired degradation of orally supplied histamine due to diamine oxidase (DAO) deficiency, a deranged gut flora may also contribute to elevated histamine levels. Our aim was to determine the intestinal bacterial composition in patients with proven histamine intolerance in comparison to other food intolerances and healthy controls. A total of 64 participants were included in the study, encompassing 8 patients with histamine intolerance...
Source: Journal of Physiology and Pharmacology - Category: Drugs & Pharmacology Tags: J Physiol Pharmacol Source Type: research
Authors: Karczewski J, Śledzińska E, Baturo A, Jończyk I, Maleszko A, Maleszko A, Samborski P, Begier-Krasińska B, Dobrowolska A Abstract The prevalence of obesity has recently increased dramatically and has contributed to the increasing prevalence of various pathological conditions, including type 2 diabetes mellitus, nonalcoholic fatty liver disease, asthma, various types of cancer, cardiovascular and neurodegenerative diseases, and others. Accumulating evidence points to localized inflammation in adipose tissue, which, in turn, promotes systemic low-grade inflammation as a primary force contributing to the d...
Source: European Cytokine Network - Category: Molecular Biology Tags: Eur Cytokine Netw Source Type: research
Authors: Bastard JP, Fellahi S, Audureau É, Layese R, Roudot-Thoraval F, Cagnot C, Mahuas-Bourcier V, Sutton A, Ziol M, Capeau J, Nahon P Abstract An obesity-related altered adipose tissue secretion is suggested as a risk factor for hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV) cirrhosis. However, no prospective study has yet examined the predictive value of circulating adipokines and immuno-inflammatory biomarkers regarding this risk. This was a case-control study nested in a prospective French national cohort of HCV-infected patients with biopsy-proven compensated cirrhosis. We se...
Source: European Cytokine Network - Category: Molecular Biology Tags: Eur Cytokine Netw Source Type: research
Publication date: 15 December 2018Source: New Scientist, Volume 240, Issue 3208Author(s): Simon IngsFancy going down in an airliner? An immersive experience nearly left Simon Ings in pieces
Source: New Scientist - Category: Science Source Type: research
Publication date: 15 December 2018Source: New Scientist, Volume 240, Issue 3208Author(s):
Source: New Scientist - Category: Science Source Type: research
More News: Allergy | Allergy & Immunology | Alzheimer's | Anemia | Burns | Cardiology | Chronic Fatigue Syndrome | Chronic Kidney Disease | Chronic Pain | Cirrhosis | Complementary Medicine | Depression | Diabetes | Dialysis | Eczema | Endocrinology | Fibromyalgia | Gastroschisis Repair | Glomerulonephritis | Heart | Heart Disease | Heart Transplant | Hepatitis | Hypertension | Immunotherapy | Kidney Transplant | Kidney Transplantation | Laser Surgery | Laser Therapy | Learning | Liver | Liver Disease | Liver Transplant | Lyme Disease | Mitochondria | Multiple Sclerosis | Pain | Parkinson's Disease | Pharmaceuticals | Pyelonephritis | Rheumatology | Stroke | Study | Tinnitus | Transplant Surgery | Transplants | Universities & Medical Training | Urology & Nephrology | Websites